Jaguar Health, Inc. (JAGX)

Jaguar Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-38.32	-41.3	-47.45	-52.6	-38.65	-44.73
Depreciation & Amortization	2.45	2.39	2.29	1.81	2.28	1.93
Share-Based Compensation	2.21	2.11	3.32	3.97	2.82	3.13
Other Operating Activities	3.32	3.56	8.74	11.84	13.43	13.03
Operating Cash Flow	-30.34	-33.24	-33.1	-34.97	-15.28	-20.46
Capital Expenditures	0	0	-0.08	-0.01	-0.01	0
Other Investing Activities	-	-	-1.6	-	-	-
Investing Cash Flow	0	0	-1.68	-0.01	-0.01	0
Share Issuance / Repurchase	27.96	33.34	20.46	33.58	7.76	6.63
Debt Issued / Paid	-0.89	-0.95	2.72	8.11	12.06	-0.1
Other Financing Activities	0.61	1.84	-	2.25	-0.33	15.25
Financing Cash Flow	27.68	34.23	23.18	43.94	19.49	21.77
Exchange Rate Effect	-0.04	0.02	0.02	0	0	0
Net Cash Flow	-2.7	1	-11.58	8.96	4.21	1.32
Free Cash Flow	-30.34	-33.24	-33.18	-34.98	-15.29	-20.46
Free Cash Flow Margin	-299.25%	-340.56%	-277.53%	-806.83%	-162.87%	-354.23%
Free Cash Flow Per Share	-11.46	-86.46	-1517.98	-3520.16	-5340.03	-55621.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).